切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (01) : 68 -72. doi: 10.3877/cma.j.issn.1674-6902.2019.01.013

所属专题: 文献

论著

慢性阻塞性肺疾病急性加重期患者病原菌分布特点
高美丽1, 赛亚飞1, 金发光2, 李王平2, 冯志军1,()   
  1. 1. 475000 开封,河南大学第一附属医院呼吸内科
    2. 710000 西安,空军军医大学(第四军医大学)唐都医院呼吸与危重症医学科
  • 收稿日期:2018-11-07 出版日期:2019-02-20
  • 通信作者: 冯志军
  • 基金资助:
    河南省科技发展计划项目(182102310238)

Chronic obstructive pulmonary disease with acute aggravating period of etiology and drug resistance analysis

Meili Gao1, Yafei Sai1, Faguang Jin2, Wangping Li2, Zhijun Feng1,()   

  1. 1. Department of Respiration, The First Affiliated Hospital of Henan University, Kaifeng 475000, China
    2. Department of Respiratory and Critical Care Medicine, Tangdu hospital, The Air Force Military Medical University, Xian 710000, China
  • Received:2018-11-07 Published:2019-02-20
  • Corresponding author: Zhijun Feng
  • About author:
    Corresponding author: Feng Zhijun, Email:
引用本文:

高美丽, 赛亚飞, 金发光, 李王平, 冯志军. 慢性阻塞性肺疾病急性加重期患者病原菌分布特点[J]. 中华肺部疾病杂志(电子版), 2019, 12(01): 68-72.

Meili Gao, Yafei Sai, Faguang Jin, Wangping Li, Zhijun Feng. Chronic obstructive pulmonary disease with acute aggravating period of etiology and drug resistance analysis[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(01): 68-72.

目的

探讨慢性阻塞性肺疾病急性加重期(AECOPD)患者病原菌分布情况,为临床规范合理使用抗菌药物提供参考。

方法

回顾性分析唐都医院呼吸与危重症医学科2014年01月至2017年10月住院的435例AECOPD患者病原菌分布特点。同时分析比较采用侵入性方法(纤维支气管镜)留取分泌物的149例患者及非侵入性方法(自然深部咳痰)留取分泌物的286例患者的病原菌检测情况。

结果

275例(63.22%)患者分离出病原菌,其中单一病原菌感染241例,混合感染34例;混合感染中,细菌混合感染16例,细菌合并真菌感染18例。870份痰样本中,合格痰标本452份,占51.95%。共检出病原菌309株,阳性率为68.36%,G 60株(19.42%),金黄色葡萄球菌24株、肺炎链球菌17株、溶血链球菌10株;G 193株(62.45%),铜绿假单胞菌56株、鲍曼/溶血不动杆菌36株、肺炎克雷伯27株;真菌56株(18.13%),其中曲霉27株、白色念珠菌25株、热带念珠菌4株。149例患者侵入法留取分泌物分离出病原菌阳性者124例,检出136株病原菌,占83.22%;286例患者用非侵入法分离出病原菌阳性者151例,检出173株病原菌,占52.80%。

结论

AECOPD患者以革兰阴性杆菌感染为主,主要是铜绿假单胞菌、鲍曼/溶血不动杆菌,但不能忽视真菌感染。支气管镜下吸取分泌物可显著提高病原菌检出率(P<0.01),AECOPD患者两种方法留取分泌物培养均以G杆菌感染为主,病原菌分布无统计学差异。

Objective

To analysis of chronic obstructive pulmonary disease in patients with acute exacerbation period (AECOPD) pathogenic bacteria distribution and use of antibiotics and provide reference for rational use of antimicrobial drugs for clinical norms.

Methods

It was collected 435 patients with acute aggravating period of COPD data from January 2014 to October 2017 for nearly three years in XiAn Tang Du hospital studied bacteria distribution and drug resistance. Besides, it was Analysis and comparison pathogenic bacteria distribution of secretions with invasive methods fiberoptic bronchoscopy of 149 cases of patients and non-invasive methods (natural deep sputum) 286 patients.

Results

The first, it was 275 patients (culture positive rate 63.22%) with isolated pathogenic bacteria, a single pathogen infection in 241 cases, 34 cases of mixed infection. Among them bacteria mixed infection in 16 cases, 18 cases of fungal infections bacteria merger. In 870 sputum samples, there were 452 sputum specimensthe qualified, accounting for 51.95%. All 309 strains pathogenic bacteria were isolated and cultured(detection positive rate 68.36%). with Gram-positive bacteria 60 strains(19.42%), staphylococcus aureus 24 strains, hemolytic streptococcus 17 strains, streptococcus pneumoniae 10 strains; Gram-negative bacteria 193 strains (62.45%), pseudomonas aeruginosa 56 strains, hemolytic acinetobacter bauman 36 strains, pneumonia klebsiella 27 strains; fungus 56 strains (18.13%), of which 27 strains aspergillus, 25 strains of candida albicans, 4 strains candida tropical. The secend, it was 124 patients with isolated pathogenic bacteria of 149 patients with invasion method to return secretion. There 136 strains of pathogenic bacteria were isolated and cultured, accounting for 83.22%. 286 patients with non-intrusive method isolated pathogenic bacteria was 151 cases. There 173 strains of pathogenic bacteria were isolated and cultured, accounting for 52.80%.

Conclusion

The first, it is given priority to AECOPD patients with gram-negative bacteria infection, mainly by pseudomonas aeruginosa and bowman/hemolytic acinetobacter.But it can′t ignore fungal infection. The secend, taking secretion under bronchoscope increased significantly pathogen detection rate (P<0.01). Patients with AECOPD were mainly infection of gram-negative bacteria, pathogen distribution no difference.

表1 275例患者病原菌分布及构成比
表2 452份痰样本分离出309株病原菌分布及构成比
表3 两种不同方法检测病原菌分布情况(株)
1
任成山,钱桂生. 慢性阻塞性肺疾病发病机制研究现状与展望[J/CD]. 中华肺部疾病杂志(电子版), 2009, 2(2): 104-115.
2
Claus F,Gerard J,Fernando J, et al. Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease[J]. Int J Respir, 2017, 22 (3): 575-601.
3
Velu PP,Fernandes SE,Laurenson IF, et al. Pulmonary My cobacterium marinum infection: fish tank granuloma of the lung[J]. Scott Med J, 2016, 61(4): 203-206.
4
钟南山. 慢性阻塞性肺疾病在中国[J]. 中国实用内科杂志,2011, 31(5): 321-322.
5
王铎,常晓悦. 慢性阻塞性肺疾病病因的研究进展[J]. 临床医药文献电子杂志,2018(28): 178-179.
6
Santos S,Marin A,Serra-Batlles J, et al. Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation[J]. Int J Chron Obstruc Pulmon Dis, 2016, 11: 515-525.
7
陈亚红. 2017年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读[J/CD]. 中国医学前沿杂志(电子版), 2017, 9(1): 37-47.
8
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志,2013, 36(4): 255-264.
9
Ye F,He LX,Cai BQ, et al. Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China[J]. Chin Med J(Engl), 2013, 126(12): 2207-2214.
10
吴倩. AECOPD病原菌分布与耐药性分析[D]. 安徽,安徽医科大学,2015: 23-31.
11
李婷,戚良燕,丛中凰. 慢性阻塞性肺疾病患者下呼吸道感染病原菌分布与耐药性分析[J]. 中国实用医药,2017, 12(16): 132-133.
12
吴传湘,周康仕. 老年人下呼吸道感染病原菌及耐药性分析[J]. 中国处方药,2018, 16(1): 44-45.
13
王浩,刘春龙,季乐财. 慢性阻塞性肺疾病急性加重期患者痰病原微生物检出状况及3年演变[J]. 中国实用医药,2017, 12(25): 24-26.
14
Valentini I,Lazzari L,Michieletto L, et al. Competence in flexible bronchoscopy and basic biopsy technique[J]. Panminerva Mde, 2018, doi: 10.23736/S0031-0808.18.03563-2.
15
徐灵彬,熊洁,孙莉,等. 老年慢性阻塞性肺疾病急性加重患者合并肺部真菌感染危险因素分析[J]. 中华医院感染学杂志,2013, 23(3): 529-531.
16
Wu X,Chen D,Gu X, et al. Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis[J]. Mol Biol Rep, 2014, 41(7): 4743-4751.
17
Hen Q,Lin MH,Chen ML, et al. Efiicacy and safety of micafungin for invasive candida infections:a meta-analysis of randomized controlled trials[J]. Chin Med J, 2012, 125(2): 345-351.
18
王雅敏,江国强,付丽,等. 慢性阻塞性肺疾病急性加重期住院患者感染病原体特点[J]. 四川医学,2017, 38(7): 809-813.
19
Lee JH,Cho MH,Hersh CP, et al. Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease[J]. Respir Res, 2014, 15(21): 113.
20
杨雪梅,朱钧,魏娜. 纤维支气管镜在ICU并发肺部感染中的临床应用[J]. 内科急危重症杂志,2014, 20(4): 268-269, 286.
21
李达才. 纤维支气管镜治疗ICU严重肺部感染的效果观察[J]. 实用中西医结合临床,2017, 17(09): 131-132.
22
史克平. 纤维支气管镜下吸痰配合支气管肺泡灌洗治疗严重肺部感染的临床效果观察[J]. 临床合理用药杂志,2018, 11(35): 137-138.
23
Liu YY,Xue FS,Li HX, et al. Comparing flexible bronchoscope and laryngoscope for tracheal intubation in critically ill patients[J]. Crit Care, 2018, 44: 464-465.
24
Scala R,Naldi M,Maccari U. Early fiberoptic bronchoscopy during non-invasive ventilation in patients with decompensated chronic obstructive pulmonary disease due to community-acquired pneumonia[J]. Crit Care, 2010, 14(2): R80.
25
田玉恒,马原,郑有光. 纤维支气管镜检查对老年难治性肺炎病原学的诊断意义[J]. 中国实用医药,2015, 10(16): 82-83.
26
周明远. 37例免疫受损患者肺部感染的诊断分析[J]. 中外医疗,2018, 37(7): 28-29.
27
de Vries JJV,Chang AB,Marchant JM. Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease[J]. Pediatr Pulmonol, 2018, 53(4): 467-474.
28
Pinchuk TP,Yasnogorodsky OO,Guryanova YV, et al. Diagnostic and curative bronchoscopy for purulent-destructive pulmonary diseases[J]. Khirurgiia(Mosk), 2017, (8): 33-39.
29
Gavaldà L,Olmo AR,Hernández R, et al. Microbiological monitoring of fiexible bronchoscopes after high-level disinfection and flushing channels with alcohol: Results and costs[J]. Respir Med, 2015, 109(8): 1079-1085.
30
Bello G,Pennisi MA,Di Muzio F, et al. Clinical impact of pulmonary sampling site in the diagnosis of ventilator-associated pneumonia: A prospective study using bronchoscopic bronchoalveolar lavage[J]. Crit Care, 2016, 33: 151-157.
31
杨晓纲,杜洁,龚思瀚,等. 高龄危重患者支气管镜检查临床意义及安全性探讨[J]. 临床肺科杂志,2018, 23(11): 2031-2033.
[1] 张海金, 王增国, 蔡慧君, 赵炳彤. 2020至2022年西安市儿童医院新生儿细菌感染分布及耐药监测分析[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 222-229.
[2] 王晓丹, 王媛, 崔向宇, 任晓磊. 上尿路结石内镜手术后尿源性脓毒血症病原菌耐药及死亡高危因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 611-615.
[3] 唐英俊, 李华娟, 王赛妮, 徐旺, 刘峰, 李羲, 郝新宝, 黄华萍. 人脐带间充质干细胞治疗COPD小鼠及机制分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 476-480.
[4] 徐丽玲, 卢玉宝, 赵彦, 任利, 李姝艺, 符娟, 康玲, 汪青松, 尤再春. COPD管理云平台的构建及临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 481-484.
[5] 李海明, 刘鸿飞, 李俊. 血清脂蛋白酶水平与COPD患者骨骼肌质量减少的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 500-503.
[6] 周杉京, 诸葛金科, 王芳芳. 补肺活血胶囊对COPD患者cCor、ALD、Ang-Ⅱ的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 517-519.
[7] 吴庆华, 冒勇, 闫效坤. AECOPD并发AKI的危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 529-531.
[8] 芦丹, 杨硕, 刘旭. VEGF、HMGB1、hs-CRP/Alb在AECOPD伴呼吸衰竭中的变化及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 532-534.
[9] 熊锋, 娄建丽. 慢性阻塞性肺疾病急性加重期预后的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 550-553.
[10] 王庆, 张红联, 吴志勇. COPD合并多重耐药菌肺部感染预后危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 557-559.
[11] 林静, 陈芳, 刘小霞. COPD患者认知功能障碍影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 569-571.
[12] 张七妹, 麦宜准, 蒋浩波. 喘可治对慢性阻塞性肺疾病缓解期的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 578-580.
[13] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[14] 廖玥, 王可, 秦江月, 吴艳秋, 陈俊, 汪涛, 文富强, 王浩. 丹龙口服液治疗轻中度慢性阻塞性肺疾病急性加重期的多中心及前瞻性研究[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 306-311.
[15] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
阅读次数
全文


摘要